SVA [SINOVAC BIOTECH] 6-K: Sinovac to Host Conference Call to Report Second

[Sinovac to Host Conference Call to Report Second Quarter 2015 Unaudited Financial Results · · Pageview: 1308 BEIJING, August 4, 2015 -- Sinovac Biotech Ltd. (Nasdaq: SVA), a leading provider of biopharmaceutical products in China, today announced that it will release its unaudited financial results for the second quarter, ended June 30, 2015, after market close on Wednesday, August 12,] [Sinovac Announces Results of 2015 Annual General Meeting of Shareholders · · Pageview: 447 BEIJING, August 11, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, today announced the results of the Company's 2015 Annual General Meeting of Shareholders held on Tuesday, August 11, 2015 in Beijing, PRC. The required quorum, a majority of] [Sinovac Reports Unaudited Second Quarter Financial Results -- Conference call scheduled for Thursday, August 13, 2015 at 8:00 AM ET · · Pageview: 254 BEIJING, Aug.12, 2015 /PRNewswire/ -- Sinovac Biotech Ltd. (SVA), a leading provider of biopharmaceutical products in China, announced today its unaudited second quarter and half year financial results for the period ended June 30, 2015. Second] []

By | 2016-03-16T06:25:05+00:00 August 13th, 2015|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q: (Original Filing)

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0315ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q0315ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T14:21:12+00:00 August 11th, 2015|Categories: Chinese Stocks, SEC Original, TPI|Tags: , , , , , |0 Comments
Read More

TPI [TIANYIN PHARMACEUTICAL] 10-Q:

[] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [CERTIFICATION OF CHIEF FINANCIAL OFFICER I, Guoqing Jiang, certify that: 1. I have reviewed this quarterly report on Form 10-Q for the period ended March 31, 2015 of Tianyin Pharmaceutical Co., Inc. 2. Based on my knowledge, this quarterly report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Chief Executive Officer, Chief Accounting Officer, Chairman EX-32.1 4 f10q0315ex32i_tianyinpharma.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (1) (2) The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company at the dates and for the periods indicated. Guoqing Jiang Acting Chief Financial Officer EX-32.2 5 f10q0315ex32ii_tianyinpharma.htm CERTIFICATION]

By | 2016-03-19T14:22:22+00:00 August 11th, 2015|Categories: Chinese Stocks, TPI, Webplus ver|Tags: , , , , , |0 Comments
Read More
Skip to toolbar